Journal News

MCP: Guidelines for reporting
complex spectra

Laurel Oldach
Sept. 1, 2018

The editors of the journal Molecular & Cellular Proteomics are seeking feedback from the proteomics community on draft guidelines for publishing proteomics studies that use data-independent acquisition, or DIA, methods. The draft guidelines can be accessed from the journal’s homepage. Comments will be accepted until the end of September.

Steven Carr is deputy editor of MCP and senior director of proteomics at the Broad Institute. “DIA is a rapidly growing research approach that can be employed on a wide variety of instrument platforms,” he said. “As such, it is important to establish rules to make sure it is properly applied.”

DIA is used to collect tandem mass spectrometry data. It offers broad coverage of the proteome with high run-to-run reproducibility.

Courtesy of Sue Weintraub
Participants at the DIA workshop in San Diego paused for a photo.

Mass spectrometers sort the ions from a sample based on their mass-to-charge ratio. In tandem mass spectrometry, there are two ionization and sorting steps. For reliable identification of a molecule, you need to know its intact precursor ion mass and also the masses produced when it is fragmented. Most strategies involve fragmenting a single precursor ion at a time.

Selection of a precursor ion can be based on observation of a peak in the first spectrum (a strategy known as data-dependent acquisition, or DDA), or it can be from a list of predetermined components of interest, i.e., targeted analysis. However, both of these approaches select only a subset of the components present for fragmentation analysis. In DIA, the whole mass range is fragmented over a series of scans. This provides fragmentation information about all components, but fragmenting multiple components at the same time produces complex spectra made of heterogeneous precursors.

With technical advances in instrumentation and computation, DIA approaches are growing in popularity, particularly for quantitative studies of sets of related samples. However, because the spectra collected using DIA are significantly more complex than data from other approaches, they can be more difficult to interpret. Complicating the situation further, there are many competing techniques for collecting DIA data, few of which have been compared directly, and researchers have yet to develop fieldwide standards around how to interpret and report results.

MCP is taking steps to ensure that future data will be described more systematically. The editors brought together 25 DIA experts from academia and industry at a satellite workshop in San Diego after the close of the American Society for Mass Spectrometry’s 2018 meeting in June. The guidelines drafted at this workshop aim to help researchers write a thorough description of how DIA data were collected and interpreted, rendering researchers’ conclusions easier to evaluate.

Among the workshop’s organizers was Robert Chalkley of the University of California, San Francisco, MCP data management editor. “When we publish the draft, we will give the opportunity for anyone in the community to send in their comments and suggestions,” he said.

MCP’s reporting guidelines for other types of mass spectrometry study have been adopted widely by other journals. MCP’s editors hope to continue to lead the field in producing guidelines that aim to allow independent assessment of the reliability of published data sets.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Spider-like proteins spin defenses to control immunity
News

Spider-like proteins spin defenses to control immunity

Oct. 17, 2025

Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.